Your browser doesn't support javascript.
loading
Galectin-1 suppression delineates a new strategy to inhibit myeloma-induced angiogenesis and tumoral growth in vivo.
Storti, P; Marchica, V; Airoldi, I; Donofrio, G; Fiorini, E; Ferri, V; Guasco, D; Todoerti, K; Silbermann, R; Anderson, J L; Zhao, W; Agnelli, L; Bolzoni, M; Martella, E; Mancini, C; Campanini, N; Noonan, D M; Petronini, P G; Neri, A; Aversa, F; Roodman, G D; Giuliani, N.
Afiliación
  • Storti P; Myeloma Unit, Department of Clinical and Experimental Medicine, University of Parma, Parma, Italy.
  • Marchica V; Myeloma Unit, Department of Clinical and Experimental Medicine, University of Parma, Parma, Italy.
  • Airoldi I; 'Laboratorio di Oncologia', Istituto Giannina Gaslini, Genova, Italy.
  • Donofrio G; Department of Medical-Veterinary Science, University of Parma, Parma, Italy.
  • Fiorini E; Myeloma Unit, Department of Clinical and Experimental Medicine, University of Parma, Parma, Italy.
  • Ferri V; Myeloma Unit, Department of Clinical and Experimental Medicine, University of Parma, Parma, Italy.
  • Guasco D; Department of Biotechnology and Life Sciences, University of Insubria, Varese, Italy.
  • Todoerti K; Myeloma Unit, Department of Clinical and Experimental Medicine, University of Parma, Parma, Italy.
  • Silbermann R; Laboratory of Pre-clinical and Translational Research, IRCCS, Rionero in Vulture, Italy.
  • Anderson JL; Hematology, Indiana University, Indianapolis, IN, USA.
  • Zhao W; Hematology, Indiana University, Indianapolis, IN, USA.
  • Agnelli L; Hematology, Indiana University, Indianapolis, IN, USA.
  • Bolzoni M; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
  • Martella E; Myeloma Unit, Department of Clinical and Experimental Medicine, University of Parma, Parma, Italy.
  • Mancini C; Pathology, 'Azienda Ospedaliero-Universitaria', Parma, Italy.
  • Campanini N; Pathology, 'Azienda Ospedaliero-Universitaria', Parma, Italy.
  • Noonan DM; Pathology, 'Azienda Ospedaliero-Universitaria', Parma, Italy.
  • Petronini PG; Department of Biotechnology and Life Sciences, University of Insubria, Varese, Italy.
  • Neri A; Department of Clinical and Experimental Medicine, University of Parma, Parma, Italy.
  • Aversa F; Pathology, 'Azienda Ospedaliero-Universitaria', Parma, Italy.
  • Roodman GD; Hematology Unit, 'Fondazione IRCCS Ca' Granda', 'Ospedale Maggiore Policlinico', Milan, Italy.
  • Giuliani N; Myeloma Unit, Department of Clinical and Experimental Medicine, University of Parma, Parma, Italy.
Leukemia ; 30(12): 2351-2363, 2016 12.
Article en En | MEDLINE | ID: mdl-27311934
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Galectina 1 / Mieloma Múltiple / Neovascularización Patológica Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2016 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Galectina 1 / Mieloma Múltiple / Neovascularización Patológica Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2016 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Reino Unido